819963008: Brolucizumab (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)\Brolucizumab (substance)

\Drug or medicament (substance)\Monoclonal antibody (substance)\Brolucizumab (substance)

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\Brolucizumab (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\Brolucizumab (substance)

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody (substance)\Brolucizumab (substance)
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody (substance)\Brolucizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3858363017 Brolucizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3858364011 Brolucizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brolucizumab (substance)	est un(e) (attribut)	Monoclonal antibody (substance)	true	Inferred relationship	Some
Brolucizumab (substance)	Has disposition (attribute)	Vascular endothelial growth factor receptor antagonist (disposition)	true	Inferred relationship	Some
Brolucizumab (substance)	est un(e) (attribut)	Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Brolucizumab only product	a pour principe actif (attribut)	True	Brolucizumab (substance)	Inferred relationship	Some	1
Brolucizumab-containing product	a pour principe actif (attribut)	True	Brolucizumab (substance)	Inferred relationship	Some	1
Brolucizumab-containing product in parenteral dose form	a pour principe actif (attribut)	True	Brolucizumab (substance)	Inferred relationship	Some	1
Product containing only brolucizumab in parenteral dose form (medicinal product form)	a pour principe actif (attribut)	True	Brolucizumab (substance)	Inferred relationship	Some	1
Product containing precisely brolucizumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has precise active ingredient	True	Brolucizumab (substance)	Inferred relationship	Some	1
Product containing precisely brolucizumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has basis of strength substance (attribute)	True	Brolucizumab (substance)	Inferred relationship	Some	1

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set